Sarioglu, Mengu <br/><br/>
Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.  [electronic resource] 

 -  Rheumatology international  Jan 2006 
 - 195-200 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0172-8172 
<br/><br/><label>Standard No.: </label>10.1007/s00296-004-0544-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alendronate--administration & dosage<br/>Alkaline Phosphatase--blood<br/>Amino Acids--blood<br/>Biomarkers--blood<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Calcium--blood<br/>Creatinine--blood<br/>Double-Blind Method<br/>Etidronic Acid--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteocalcin--blood<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Risedronic Acid